The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ATYR PHARMA INC | COM | 002120103 | 889 | 279,425 | SH | SOLE | 279,425 | 0 | 0 | ||
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 8,347 | 90,215 | SH | SOLE | 90,215 | 0 | 0 | ||
| CYCLACEL PHARMACEUTICALS INC | COM | 23254L405 | 2,159 | 359,900 | SH | SOLE | 359,900 | 0 | 0 | ||
| HERON THERAPEUTICS INC | COM | 427746102 | 101,207 | 5,873,891 | SH | SOLE | 5,873,891 | 0 | 0 | ||
| HERON THERAPEUTICS INC | COM | 427746102 | 5,571 | 323,307 | SH | OTR | 1 | 0 | 323,307 | 0 | |
| IGNYTA INC | COM | 451731103 | 24,989 | 3,972,800 | SH | SOLE | 3,972,800 | 0 | 0 | ||
| LA JOLLA PHARMACEUTICAL CO | COM | 503459604 | 75,918 | 3,191,165 | SH | SOLE | 3,191,165 | 0 | 0 | ||
| OPKO HEALTH INC | DEBT 3.0% 2/1/33 | 68375NAB9 | 22,031 | 14,000,000 | PRN | SOLE | 14,000,000 | 0 | 0 | ||